Apply For a Grant
2010 IVY REQUEST FOR PROPOSALS (RFP)
About the Ivy Foundation
The Ben and Catherine Ivy Foundation is a non-profit organization that funds Patient-Focused Research on gliomas leading to the development of better diagnostics and treatment that offer long-term survival and a high quality of life for patients with brain tumors. Since our inception in 2007, the Foundation has funded $20.2M in glioma research.
Patient-Focused Research
Copyright © 2009. The Ben and Catherine Ivy Foundation. All rights reserved.
Patient-Focused Research is defined by:
- the promotion of bi-directional efforts between the lab and the clinic, whereby medical insights gained from the clinic are followed up in the lab for further exploration and, vice versa, findings from the lab are applied to identify promising directions to pursue in the clinic.
- the recognition of the need to develop diagnostics and treatments to address inter-patient variations that underlie differences in response to treatment.
- a strong sense of urgency to change the outlook for patients.
- collaborative efforts, either between institutions or disciplines.
- the acknowledgement that patients play a key role in the brain tumor research landscape by providing tumor and other tissue samples for laboratory studies and by participating in clinical trials.
- generating clinically relevant results by keeping the patient at the center of research goals.
Today's treatment decision-making for people diagnosed with glioma is largely based on trial-and-error and one-size-fits-all approaches. There are few options to select from and, moreover, the most effective treatments generally extend survival on the order of a few months at best.
Ivy funds PFR to help realize "Tomorrow's" optimal scenario in treatment decision-making for patients - one characterized by a broad panel of highly effective therapies and more predictive, patient-specific approaches to treatment and disease management. The "Tomorrow" scenario also integrates accurate and predictive real-time assessment of tumor status and response to therapy (Figure 1).
Copyright © 2009. The Ben and Catherine Ivy Foundation. All rights reserved.
The Ivy Foundation funds milestone-driven, single and multi-year research projects. Research funding programs are designed to catalyze improvements in research areas critical to realizing "Tomorrow's" scenario for people diagnosed with glioma. A description of 2008 and 2009 Ivy funded research projects is available on our website.
REQUEST SPECIFICS
Guided by its strategic plan and mission, the Ivy Foundation is interested in funding projects on the leading edge whose primary objective is to accomplish one or more of the following in a 12-month project period starting no later than July 2010:
- Enhance the output of a clinical trial for adults with GBM by performing correlative studies which significantly increase understanding of the biologic impact of a candidate therapeutic and/or interpretation of clinical response data.
- Identify or validate predictors of therapeutic responsiveness by GBM molecular subtype that could potentially lead to patient stratification for therapy selection.
- Determine preliminary efficacy of novel candidate therapies or validate novel therapeutic targets in GBM models.
Research proposals MUST:
- Focus on one or more of the three objectives outlined above, AND
- Generate definitive results that are actionable, AND
- Focus on adult GBM, AND
- Clearly delineate relevance of GBM model to patient tumor biology (if employing GBM model).
Successful applications will LIKELY:
- Involve conducting studies in patients or in patient-derived tissue specimens.
- Be collaborative, multi-institutional and/or multi-disciplinary efforts.
- Have clinical outcomes data available very early on in project period if study is related to a clinical trial.
PROGRAM HIGHLIGHTS
- Date of issue of RFP: Tuesday, 02/23/2010.
- Deadline for receipt of proposals: Monday, 03/22/2010 at 12 noon (Pacific Time).
- Project period: 12 months.
- Total funds to be distributed: up to $1M.
- Total budget per project: up to $150,000 maximum.
- Scientific review process: Two-step process comprised of an Intermediate Scientific Review followed by a Final Scientific Review.
- Notification to all applicants of outcome of the Intermediate Scientific Review: May 2010.
- Notification of outcome of the Final Scientific Review: June 2010.
- Eligibility: Only early-career researchers who received their MD and/or PhD in the last 10 years (i.e., in 2000 or after) are eligible to apply as Principal Investigator (PI) or co-PI. Both the PI and co-PI must meet the eligibility requirements for early career researcher. Applicants must be affiliated with a non-profit institution or for-profit organization in the US or abroad. Joint applications between academic institution(s) and for-profit entities are accepted. There is no limit on the number of applications per PI or per institution. PIs of projects currently receiving Ivy funding are not eligible to apply as PI or co-PI.
- Project start date: July 2010.
INSTRUCTIONS FOR COMPLETING THE 2010 IVY FOUNDATION APPLICATION
The research proposal must be submitted as a single PDF document in 12-pt font size, 1-inch margins and must conform to the page limitations, content and organization specified below under the heading “Required Content”.
Research proposals which do not conform to the specifications and requirements will not be considered for funding.
The PDF document must be titled exactly as shown with name of Principal Investigator and year of award cycle: Garcia_Sara2010. The name of the Principal Investigator and year of award cycle must be also included as a header on each page of the research proposal PDF.
If there is more than one PI on the proposal, use the name of the PI who is the "Contact" PI for correspondence with the Ivy Foundation during the grant submission and review process.
Research proposals must be submitted on-line by Monday, March 22, 2010 at 12 noon (Pacific Time). In fairness to all applicants, proposals submitted after the deadline will not be accepted.
